Mind + Muscle

technical minds + legal muscle

Bracket

dig deep

Practice Considerations Post Teva v. Sandoz

  • 01.30.15
  • Daniel E. Yonan and Jon E. Boljesic
  • Sterne, Kessler, Goldstein & Fox

In Teva Pharmaceuticals USA, Inc. v. Sandoz, Inc., No. 13-854, slip op. 574 U.S. __ (2015), the U.S. Supreme Court ruled that underlying factual issues resolved while formally construing a disputed patent claim term at the district court level are subject to a clear error standard of review as opposed to a de novo standard.

This alert, authored by Daniel E. Yonan and Jon E. Boljesic, discusses the Supreme Court's decision and explains the significance of the Teva holding on patent prosecution and enforcement.

To read the full alert, download the attached PDF.

Related People

Related Services

Related Industries

Sort By Media Type

Sort By Media Type
  • AlertAlert
  • BriefsBriefs
  • Comments to USPTOComments to USPTO
  • Design Patent Case DigestDesign Patent Case Digest
  • MultimediaMultimedia
  • News & ArticlesNews & Articles
  • Press ReleasePress Release
  • VideoVideo
  • WebinarWebinar
X

Unsolicited e-mails and information sent to Sterne, Kessler, Goldstein & Fox P.L.L.C. will not be considered confidential or privileged, may be disclosed to others, may not receive a response, and do not create an attorney-client relationship with Sterne Kessler.  If you are not already a client of Sterne Kessler, do not include any confidential information in this message.